212 related articles for article (PubMed ID: 37266816)
1. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
[TBL] [Abstract][Full Text] [Related]
2. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic.
Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F
Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003
[TBL] [Abstract][Full Text] [Related]
3. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
[TBL] [Abstract][Full Text] [Related]
4. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
[TBL] [Abstract][Full Text] [Related]
5. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study.
Fargeot G; Echaniz-Laguna A; Labeyrie C; Svahn J; Camdessanché JP; Cintas P; Chanson JB; Esselin F; Piedvache C; Verstuyft C; Genestet S; Lagrange E; Magy L; Péréon Y; Sacconi S; Signate A; Nadaj-Pakleza A; Taithe F; Viala K; Tard C; Poinsignon V; Cauquil C; Attarian S; Adams D
Amyloid; 2024 Mar; 31(1):62-69. PubMed ID: 37855400
[TBL] [Abstract][Full Text] [Related]
6. A compound score to screen patients with hereditary transthyretin amyloidosis.
Tozza S; Severi D; Spina E; Di Paolantonio A; Iovino A; Guglielmino V; Aruta F; Nolano M; Sabatelli M; Santoro L; Luigetti M; Manganelli F
J Neurol; 2022 Aug; 269(8):4281-4287. PubMed ID: 35279758
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):668-678. PubMed ID: 35256455
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis.
Berends M; Brunger AF; Bijzet J; Kroesen BJ; Drost G; Lange F; Teunissen CE; In 't Veld S; Vrancken AF; Gans ROB; Hazenberg BPC; van der Zwaag PA; Nienhuis HLA
Amyloid; 2024 Jun; 31(2):132-141. PubMed ID: 38477065
[TBL] [Abstract][Full Text] [Related]
10. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
[TBL] [Abstract][Full Text] [Related]
11. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
Leonardi L; Vanoli F; Fionda L; Loreti S; Garibaldi M; Morino S; Salvetti M; Russo D; Musumeci B; Antonini G
Neurol Sci; 2020 Dec; 41(12):3775-3778. PubMed ID: 32936357
[TBL] [Abstract][Full Text] [Related]
12. Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy.
Ueda M; Misumi Y; Nomura T; Tasaki M; Yamakawa S; Obayashi K; Yamashita T; Ando Y
Ann Neurol; 2024 Feb; 95(2):230-236. PubMed ID: 38053464
[TBL] [Abstract][Full Text] [Related]
13. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
[TBL] [Abstract][Full Text] [Related]
14. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.
Kaku MC; Bhadola S; Berk JL; Sanchorawala V; Connors LH; Lau KHV
Amyloid; 2022 Sep; 29(3):184-189. PubMed ID: 35253562
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
[TBL] [Abstract][Full Text] [Related]
16. Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis.
Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S
Clin Neurophysiol; 2024 Mar; 159():81-95. PubMed ID: 38377648
[TBL] [Abstract][Full Text] [Related]
17. 3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy.
Hodel J; Benadjaoud S; Benadjaoud MA; Lefaucheur JP; Planté-Bordeneuve V
Eur Radiol; 2022 Nov; 32(11):7865-7871. PubMed ID: 35438324
[TBL] [Abstract][Full Text] [Related]
18. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.
Leonardi L; Adam C; Beaudonnet G; Beauvais D; Cauquil C; Not A; Morassi O; Benmalek A; Trassard O; Echaniz-Laguna A; Adams D; Labeyrie C
Eur J Neurol; 2022 May; 29(5):1477-1487. PubMed ID: 35100482
[TBL] [Abstract][Full Text] [Related]
19. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.
Lyng CS; Gude E; Hodt A; Knudsen EC
Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts.
Karam C; Mauermann ML; Gonzalez-Duarte A; Kaku MC; Ajroud-Driss S; Brannagan TH; Polydefkis M
Muscle Nerve; 2024 Mar; 69(3):273-287. PubMed ID: 38174864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
